Huang et al. reported that acid sphingomyelins produced by ceramide can participate in regulating NLRP3 inflammasome activation and inflammatory exosome release in podocytes during obesity via the ceramide signaling pathway, resulting in glomerular inflammation and injury associated with obesity-related glomerulopathy (Huang et al., 2023). Here, NLRP3 is linked to Obesity.